- Home
- ESLA vs RPID Comparison
ESLA vs RPID Comparison
Compare ESLA & RPID Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESLA
- RPID
- Stock Information
- Founded
- ESLA 2021
- RPID 2006
- Country
- ESLA United States
- RPID United States
- Employees
- ESLA N/A
- RPID N/A
- Industry
- ESLA Biotechnology: Biological Products (No Diagnostic Substances)
- RPID Medical Specialities
- Sector
- ESLA Health Care
- RPID Health Care
- Exchange
- ESLA Nasdaq
- RPID Nasdaq
- Market Cap
- ESLA 41.6M
- RPID 37.3M
- IPO Year
- ESLA N/A
- RPID 2021
- Fundamental
- Price
- ESLA $0.91
- RPID $1.15
- Analyst Decision
- ESLA
- RPID
- Analyst Count
- ESLA 0
- RPID 0
- Target Price
- ESLA N/A
- RPID N/A
- AVG Volume (30 Days)
- ESLA 16.9K
- RPID 96.9K
- Earning Date
- ESLA 11-14-2024
- RPID 11-01-2024
- Dividend Yield
- ESLA N/A
- RPID N/A
- EPS Growth
- ESLA N/A
- RPID N/A
- EPS
- ESLA N/A
- RPID N/A
- Revenue
- ESLA N/A
- RPID $26,170,000.00
- Revenue This Year
- ESLA N/A
- RPID $24.34
- Revenue Next Year
- ESLA N/A
- RPID $19.49
- P/E Ratio
- ESLA N/A
- RPID N/A
- Revenue Growth
- ESLA N/A
- RPID 27.31
- 52 Week Low
- ESLA $0.63
- RPID $0.58
- 52 Week High
- ESLA $3.23
- RPID $1.34
- Technical
- Relative Strength Index (RSI)
- ESLA 53.92
- RPID 58.93
- Support Level
- ESLA $0.74
- RPID $1.01
- Resistance Level
- ESLA $0.99
- RPID $1.19
- Average True Range (ATR)
- ESLA 0.09
- RPID 0.11
- MACD
- ESLA 0.02
- RPID -0.01
- Stochastic Oscillator
- ESLA 72.88
- RPID 42.42
About ESLA Estrella Immunopharma Inc.
Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors. Estrella's mission is to harness the evolutionary power of the human immune system to transform the lives of patients fighting cancer and autoimmune diseases.
About RPID Rapid Micro Biosystems Inc.
Rapid Micro Biosystems Inc is an life sciences technology company providing mission critical automation solutions to facilitate the efficient manufacturing and fast, safe release of healthcare products such as biologics, vaccines, cell and gene therapies, and sterile injectables. The company's flagship Growth Direct platform automates and modernizes the antiquated, manual microbial quality control (MQC) testing workflows used in the pharmaceutical manufacturing operations across the globe. It derives revenue from development, manufacturing, marketing and selling Systems and related LIMS connection software, consumables and services.